GLP-1 receptor agonists and risk of cancer in type 2 diabetes: an updated meta-analysis of randomized controlled trials
Sign Up to like & getrecommendations! Published in 2019 at "Endocrine"
DOI: 10.1007/s12020-019-02055-z
Abstract: Some preliminary studies reported a link between GLP-1 receptor agonists (GLP-1RAs) and thyroid/pancreatic neoplasms, while its human relevance remained undetermined. The present meta-analysis was performed to collect information on cancers associated with GLP-1RAs in patients… read more here.
Keywords: risk; glp 1ras; overall cancer; cancer ... See more keywords
Sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors on new-onset overall cancer in type 2 diabetes mellitus: a population-based study
Sign Up to like & getrecommendations! Published in 2022 at "Cancer medicine"
DOI: 10.1101/2022.07.21.22277915
Abstract: Background: There is much uncertainty regarding the comparative risks of cancer for T2DM patients on SGLT2I versus DPP4I. Methods: This population-based cohort study patients included T2DM patients who were administered with either SGLT2I or DPP4I… read more here.
Keywords: new onset; overall cancer; population based; onset overall ... See more keywords
Genetic Risk for Overall Cancer and the Benefit of Adherence to a Healthy Lifestyle
Sign Up to like & getrecommendations! Published in 2021 at "Cancer Research"
DOI: 10.1158/0008-5472.can-21-0836
Abstract: A new indicator of cancer polygenic risk score measures genetic risk for overall cancer, which could identify individuals with high cancer risk to facilitate decision-making about lifestyle modifications for personalized prevention. Cancer site–specific polygenic risk… read more here.
Keywords: genetic risk; risk overall; cancer; risk ... See more keywords